Patients and methods
Results
Previous operations | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Unknown | Suture | Open mesh | Endoscopic mesh | |||||||
N
| % |
N
| % |
N
| % |
N
| % |
N
| % | |
Recurrent operation | ||||||||||
Endoscopic | 3 | 0.1 |
1528
|
61.6
|
718
|
28.9
| 233 | 9.4 | 2482 | 100.0 |
Open | 10 | 0.4 | 1011 | 43.4 | 412 | 17.7 |
897
|
38.5
| 2330 | 100.0 |
Total | 13 | 0.3 | 2539 | 52.8 | 1130 | 23.5 | 1130 | 23.5 | 4812 | 100.0 |
Operation |
p
| |||
---|---|---|---|---|
Endoscopic | Open | |||
Age (years) | Mean ± STD | 58.9 ± 15.6 | 59.3 ± 15.3 | 0.440 |
BMI (kg/m2) | Mean ± STD | 25.9 ± 3.4 | 26.3 ± 3.6 | 0.004 |
Endoscopic | Open |
p
| ||||
---|---|---|---|---|---|---|
n
| % |
n
| % | |||
ASA score | I | 561 | 24.98 | 257 | 28.65 | 0.091 |
II | 1302 | 57.97 | 502 | 55.96 | ||
III/IV | 383 | 17.05 | 138 | 15.38 | ||
Defect size | I (<1.5 cm) | 417 | 18.57 | 151 | 16.83 | <0.001 |
II (1.5–3 cm) | 1459 | 64.96 | 493 | 54.96 | ||
III (>3 cm) | 370 | 16.47 | 253 | 28.21 | ||
EHS-classification medial | Yes | 1112 | 49.51 | 518 | 57.75 | <0.001 |
No | 1134 | 50.49 | 379 | 42.25 | ||
EHS-classification lateral | Yes | 1351 | 60.15 | 452 | 50.39 | <0.001 |
No | 895 | 39.85 | 445 | 49.61 | ||
EHS-classification femoral | Yes | 77 | 3.43 | 15 | 1.67 | 0.007 |
No | 2169 | 96.57 | 882 | 98.33 | ||
EHS-classification scrotal | Yes | 27 | 1.20 | 12 | 1.34 | 0.724 |
No | 2219 | 98.80 | 885 | 98.66 | ||
Risk factor | ||||||
Total | Yes | 687 | 30.59 | 275 | 30.66 | 0.966 |
No | 1559 | 69.41 | 622 | 69.34 | ||
COPD | Yes | 151 | 6.72 | 66 | 7.36 | 0.534 |
No | 2095 | 93.28 | 831 | 92.64 | ||
Diabetes | Yes | 129 | 5.74 | 51 | 5.69 | 1.000 |
No | 2117 | 94.26 | 846 | 94.31 | ||
Aortic aneurism | Yes | 16 | 0.71 | 4 | 0.45 | 0.467 |
No | 2230 | 99.29 | 893 | 99.55 | ||
Immunosuppression | Yes | 14 | 0.62 | 10 | 1.11 | 0.174 |
No | 2232 | 99.38 | 887 | 98.89 | ||
Corticoids | Yes | 20 | 0.89 | 8 | 0.89 | 1.000 |
No | 2226 | 99.11 | 889 | 99.11 | ||
Smoking | Yes | 262 | 11.67 | 110 | 12.26 | 0.669 |
No | 1984 | 88.33 | 787 | 87.74 | ||
Coagulopathy | Yes | 33 | 1.47 | 9 | 1.00 | 0.390 |
No | 2213 | 98.53 | 888 | 99.00 | ||
Antiplatelet medication | Yes | 202 | 8.99 | 79 | 8.81 | 0.890 |
No | 2044 | 91.01 | 818 | 91.19 | ||
Anticoagulation therapy | Yes | 44 | 1.96 | 25 | 2.79 | 0.177 |
No | 2202 | 98.04 | 872 | 97.21 |
Endoscopic | Open |
p
| ||||
---|---|---|---|---|---|---|
n
| % |
n
| % | |||
Intraoperative complication | ||||||
Total | Yes | 26 | 1.16 | 14 | 1.56 | 0.380 |
No | 2220 | 98.84 | 883 | 98.44 | ||
Bleeding | Yes | 15 | 0.67 | 3 | 0.33 | 0.431 |
No | 2231 | 99.33 | 894 | 99.67 | ||
Injuries | ||||||
Total | Yes | 17 | 0.76 | 12 | 1.34 | 0.147 |
No | 2229 | 99.24 | 885 | 98.66 | ||
Vascular | Yes | 8 | 0.36 | 0 | 0.00 | 0.115 |
No | 2238 | 99.64 | 897 | 100.0 | ||
Bowel | Yes | 5 | 0.22 | 0 | 0.00 | 0.330 |
No | 2241 | 99.78 | 897 | 100.0 | ||
Bladder | Yes | 2 | 0.09 | 1 | 0.11 | 1.000 |
No | 2244 | 99.91 | 896 | 99.89 | ||
Nerve | Yes | 0 | 0.00 | 9 | 1.00 | <0.001 |
No | 2246 | 100.0 | 888 | 99.00 | ||
Postoperative complication | ||||||
Total | Yes | 80 | 3.56 | 33 | 3.68 | 0.916 |
No | 2166 | 96.44 | 864 | 96.32 | ||
Bleeding | Yes | 29 | 1.29 | 17 | 1.90 | 0.248 |
No | 2217 | 98.71 | 880 | 98.10 | ||
Seroma | Yes | 51 | 2.27 | 14 | 1.56 | 0.266 |
No | 2195 | 97.73 | 883 | 98.44 | ||
Bowell injury/anastomotic leakage | Yes | 1 | 0.04 | 0 | 0.00 | 1.000 |
No | 2245 | 99.96 | 897 | 100.0 | ||
Wound healing disorders | Yes | 2 | 0.09 | 4 | 0.45 | 0.059 |
No | 2244 | 99.91 | 893 | 99.55 | ||
Ileus | – | – | – | – | – | – |
No | 2246 | 100.0 | 897 | 100.0 | ||
Reoperations | Yes | 27 | 1.20 | 9 | 1.00 | 0.714 |
No | 2219 | 98.80 | 888 | 99.00 | ||
Recurrence on follow-up | Yes | 28 | 1.25 | 10 | 1.11 | 0.858 |
No | 2218 | 98.75 | 887 | 98.89 | ||
Pain in rest on follow-up | Yes | 133 | 5.92 | 78 | 8.70 | 0.007 |
No | 2113 | 94.08 | 819 | 91.30 | ||
Pain on exertion on follow-up | Yes | 250 | 11.13 | 135 | 15.05 | 0.003 |
No | 1996 | 88.87 | 762 | 84.95 | ||
Pain requiring treatment | Yes | 85 | 3.78 | 40 | 4.46 | 0.419 |
No | 2161 | 96.22 | 857 | 95.54 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
EHS-classification medial | 0.017 | Yes versus no | 0.427 | 0.213 | 0.857 |
Age (10-year OR) | 0.081 | 1.148 | 0.983 | 1.339 | |
Defect size | 0.118 | II (1.5–3 cm) versus I (<1.5 cm) | 0.848 | 0.502 | 1.434 |
III (>3 cm) versus I (<1.5 cm) | 1.382 | 0.756 | 2.526 | ||
Risk factors | 0.139 | Yes versus no | 1.371 | 0.903 | 2.083 |
BMI (five-point OR) | 0.155 | 0.807 | 0.600 | 1.085 | |
ASA score | 0.306 | II versus I | 0.817 | 0.486 | 1.370 |
III/IV versus I | 1.177 | 0.600 | 2.308 | ||
EHS-classification lateral | 0.372 | Yes versus no | 0.723 | 0.354 | 1.474 |
EHS-classification femoral | 0.647 | Yes versus no | 1.263 | 0.466 | 3.426 |
Operation | 0.772 | Endoscopic versus open | 0.939 | 0.616 | 1.434 |
EHS-classification scrotal | 0.862 | Yes versus no | 1.121 | 0.308 | 4.077 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
BMI (five-point OR) | 0.001 | 1.351 | 1.127 | 1.620 | |
Operation | 0.004 | Endoscopic versus open | 0.643 | 0.476 | 0.868 |
Defect size | 0.021 | II (1.5–3 cm) versus I (<1.5 cm) | 0.794 | 0.562 | 1.123 |
III (>3 cm) versus I (<1.5 cm) | 0.500 | 0.307 | 0.815 | ||
Age (10-year OR) | 0.064 | 0.902 | 0.809 | 1.006 | |
EHS-classification lateral | 0.087 | Yes versus no | 0.629 | 0.370 | 1.070 |
EHS-classification medial | 0.122 | Yes versus no | 0.659 | 0.389 | 1.118 |
Risk factor | 0.129 | Yes versus no | 1.278 | 0.931 | 1.754 |
EHS-classification femoral | 0.834 | Yes versus no | 0.913 | 0.392 | 2.130 |
ASA score | 0.888 | II versus I | 0.917 | 0.643 | 1.307 |
III/IV versus I | 0.943 | 0.552 | 1.610 | ||
EHS-classification scrotal | 0.974 | Yes versus no | 0.000 | 0.000 | I |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
Age (10-year OR) | <0.001 | 0.825 | 0.760 | 0.897 | |
Defect size | <0.001 | II (1.5–3 cm) versus I (<1.5 cm) | 0.704 | 0.541 | 0.916 |
III (>3 cm) versus I (<1.5 cm) | 0.479 | 0.331 | 0.693 | ||
Operation | 0.001 | Endoscopic versus open | 0.679 | 0.537 | 0.857 |
BMI (five-point OR) | 0.003 | 1.251 | 1.081 | 1.449 | |
EHS-classification lateral | 0.018 | Yes versus no | 0.624 | 0.422 | 0.922 |
EHS-classification scrotal | 0.094 | Yes versus no | 0.178 | 0.024 | 1.339 |
EHS-classification medial | 0.180 | Yes versus no | 0.765 | 0.517 | 1.131 |
Risk factor | 0.512 | Yes versus no | 1.087 | 0.847 | 1.393 |
ASA score | 0.764 | II versus I | 0.981 | 0.749 | 1.285 |
III/IV versus I | 1.114 | 0.737 | 1.682 | ||
EHS-classification femoral | 0.933 | Yes versus no | 0.973 | 0.511 | 1.850 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
BMI (five-point OR) | 0.014 | 1.320 | 1.058 | 1.647 | |
EHS-classification lateral | 0.051 | Yes versus no | 0.494 | 0.243 | 1.004 |
Age (10-year OR) | 0.053 | 0.871 | 0.758 | 1.002 | |
EHS-classification medial | 0.054 | Yes versus no | 0.501 | 0.248 | 1.012 |
ASA score | 0.240 | II versus I | 1.048 | 0.654 | 1.679 |
III/IV versus I | 1.607 | 0.834 | 3.094 | ||
Risk factor | 0.253 | Yes versus no | 1.263 | 0.846 | 1.886 |
Operation | 0.260 | Endoscopic versus open | 0.797 | 0.538 | 1.182 |
Defect size | 0.294 | II (1.5–3 cm) versus I (<1.5 cm) | 0.944 | 0.597 | 1.493 |
III (>3 cm) versus I (<1.5 cm) | 0.634 | 0.338 | 1.191 | ||
EHS-classification femoral | 0.476 | Yes versus no | 1.390 | 0.561 | 3.445 |
EHS-classification scrotal | 0.979 | Yes versus no | 0.000 | 0.000 | I |
Previous operations | Total | |||||||
---|---|---|---|---|---|---|---|---|
Suture | Open mesh | Endoscopic mesh | ||||||
N
| ColPctN |
N
| ColPctN |
N
| ColPctN |
N
| ColPctN | |
Guidelines | ||||||||
No | – | – | – | – | 233 | 100.0 | 233 | 9.4 |
Yes | 1528 | 100.0 | 718 | 100.0 | – | – | 2246 | 90.6 |
Total | 1528 | 100.0 | 718 | 100.0 | 233 | 100.0 | 2479 | 100.0 |
Guidelines |
p
| |||
---|---|---|---|---|
Yes | No | |||
Age (years) | Mean ± STD | 58.9 ± 15.6 | 60.1 ± 14.2 | 0.199 |
BMI | Mean ± STD | 25.9 ± 3.4 | 26.2 ± 3.0 | 0.306 |
Guideline |
p
| |||||
---|---|---|---|---|---|---|
Yes | No | |||||
n
| % |
n
| % | |||
ASA score | I | 562 | 24.99 | 59 | 25.32 | 0.992 |
II | 1303 | 57.94 | 134 | 57.51 | ||
III/IV | 384 | 17.07 | 40 | 17.17 | ||
Defect size | I (<1.5 cm) | 419 | 18.63 | 34 | 14.59 | 0.001 |
II (1.5–3 cm) | 1460 | 64.92 | 139 | 59.66 | ||
III (>3 cm) | 370 | 16.45 | 60 | 25.75 | ||
Risk factor | ||||||
Total | Yes | 687 | 30.55 | 60 | 25.75 | 0.129 |
No | 1562 | 69.45 | 173 | 74.25 | ||
COPD | Yes | 151 | 6.71 | 14 | 6.01 | 0.681 |
No | 2098 | 93.29 | 219 | 93.99 | ||
Diabetes | Yes | 129 | 5.74 | 10 | 4.29 | 0.361 |
No | 2120 | 94.26 | 223 | 95.71 | ||
Aortic aneurism | Yes | 16 | 0.71 | 1 | 0.43 | 0.619 |
No | 2233 | 99.29 | 232 | 99.57 | ||
Immunosuppression | Yes | 14 | 0.62 | 1 | 0.43 | 0.717 |
No | 2235 | 99.38 | 232 | 99.57 | ||
Corticoids | Yes | 20 | 0.89 | 1 | 0.43 | 0.465 |
No | 2229 | 99.11 | 232 | 99.57 | ||
Smoking | Yes | 262 | 11.65 | 30 | 12.88 | 0.580 |
No | 1987 | 88.35 | 203 | 87.12 | ||
Coagulopathy | Yes | 33 | 1.47 | 3 | 1.29 | 0.827 |
No | 2216 | 98.53 | 230 | 98.71 | ||
Antiplatelet medication | Yes | 202 | 8.98 | 15 | 6.44 | 0.191 |
No | 2047 | 91.02 | 218 | 93.56 | ||
Anticoagulation therapy | Yes | 44 | 1.96 | 4 | 1.72 | 0.800 |
No | 2205 | 98.04 | 229 | 98.28 | ||
EHS-classification medial | Yes | 1115 | 49.58 | 120 | 51.50 | 0.576 |
No | 1134 | 50.42 | 113 | 48.50 | ||
EHS-classification lateral | Yes | 1351 | 60.07 | 118 | 50.64 | 0.005 |
No | 898 | 39.93 | 115 | 49.36 | ||
EHS-classification femoral | Yes | 77 | 3.42 | 6 | 2.58 | 0.493 |
No | 2172 | 96.58 | 227 | 97.42 | ||
EHS-classification scrotal | Yes | 27 | 1.20 | 5 | 2.15 | 0.223 |
No | 2222 | 98.80 | 228 | 97.85 |
Guidelines |
p
| |||||
---|---|---|---|---|---|---|
Yes | No | |||||
n
| % |
n
| % | |||
Intraoperative complication | ||||||
Total | Yes | 26 | 1.16 | 7 | 3.00 | 0.019 |
No | 2223 | 98.84 | 226 | 97.00 | ||
Bleeding | Yes | 15 | 0.67 | 7 | 3.00 | <0.001 |
No | 2234 | 99.33 | 226 | 97.00 | ||
Injury | ||||||
Total | Yes | 17 | 0.76 | 3 | 1.29 | 0.388 |
No | 2232 | 99.24 | 230 | 98.71 | ||
Vascular | Yes | 8 | 0.36 | 3 | 1.29 | 0.042 |
No | 2241 | 99.64 | 230 | 98.71 | ||
Bowell | Yes | 5 | 0.22 | 0 | 0.00 | 0.471 |
No | 2244 | 99.78 | 233 | 100.0 | ||
Bladder | Yes | 2 | 0.09 | 0 | 0.00 | 0.649 |
No | 2247 | 99.91 | 233 | 100.0 | ||
Postoperative complication | ||||||
Total | Yes | 80 | 3.56 | 20 | 8.58 | <0.001 |
No | 2169 | 96.44 | 213 | 91.42 | ||
Bleeding | Yes | 29 | 1.29 | 6 | 2.58 | 0.113 |
No | 2220 | 98.71 | 227 | 97.42 | ||
Seroma | Yes | 51 | 2.27 | 14 | 6.01 | <0.001 |
No | 2198 | 97.73 | 219 | 93.99 | ||
Infection | Yes | 1 | 0.04 | 0 | 0.00 | 0.748 |
No | 2248 | 99.96 | 233 | 100.0 | ||
Bowell injury | Yes | 1 | 0.04 | 0 | 0.00 | 0.748 |
No | 2248 | 99.96 | 233 | 100.0 | ||
Wound healing disorders | Yes | 1 | 0.04 | 0 | 0.00 | 0.748 |
No | 2248 | 99.96 | 233 | 100.0 | ||
Reoperations | Yes | 27 | 1.20 | 6 | 2.58 | 0.081 |
No | 2222 | 98.80 | 227 | 97.42 | ||
Recurrence on follow-up | Yes | 28 | 1.24 | 8 | 3.43 | 0.008 |
No | 2221 | 98.76 | 225 | 96.57 | ||
Pain in rest on follow-up | Yes | 133 | 5.91 | 20 | 8.58 | 0.107 |
No | 2116 | 94.09 | 213 | 91.42 | ||
Pain on exertion on follow-up | Yes | 250 | 11.12 | 34 | 14.59 | 0.113 |
No | 1999 | 88.88 | 199 | 85.41 | ||
Pain requiring treatment on follow-up | Yes | 85 | 3.78 | 10 | 4.29 | 0.698 |
No | 2164 | 96.22 | 223 | 95.71 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
Guidelines | 0.001 | Yes versus no | 0.419 | 0.248 | 0.708 |
Defect size | 0.018 | II (1.5–3 cm) versus I (<1.5 cm) | 1.256 | 0.656 | 2.404 |
III (>3 cm) versus I (<1.5 cm) | 2.329 | 1.135 | 4.779 | ||
Age (10-year OR) | 0.089 | 1.152 | 0.979 | 1.357 | |
EHS-classification medial | 0.115 | Yes versus no | 0.572 | 0.285 | 1.146 |
Risk factor | 0.269 | Yes versus no | 1.293 | 0.820 | 2.038 |
BMI (five-point OR) | 0.420 | 0.876 | 0.634 | 1.210 | |
EHS-classification femoral | 0.429 | Yes versus no | 1.485 | 0.558 | 3.953 |
EHS-classification lateral | 0.532 | Yes versus no | 0.797 | 0.392 | 1.621 |
EHS-classification scrotal | 0.612 | Yes versus no | 1.378 | 0.399 | 4.758 |
ASA score | 0.657 | II versus I | 0.849 | 0.484 | 1.489 |
III/IV versus I | 1.056 | 0.512 | 2.179 |
Previous operations | Total | |||||||
---|---|---|---|---|---|---|---|---|
Suture | Open mesh | Endoscopic mesh | ||||||
N
| ColPctN |
N
| ColPctN |
N
| ColPctN |
N
| ColPctN | |
Guidelines | ||||||||
No | 1011 | 100.0 | 412 | 100.0 | – | – | 1423 | 61.3 |
Yes | – | – | – | – | 897 | 100.0 | 897 | 38.7 |
Total | 1011 | 100.0 | 412 | 100.0 | 897 | 100.0 | 2320 | 100.0 |
Guidelines |
p
| |||
---|---|---|---|---|
Yes | No | |||
Age (years) | Mean ± STD | 59.3 ± 13.5 | 62.5 ± 16.2 | <0.001 |
BMI | Mean ± STD | 26.3 ± 3.6 | 25.8 ± 3.4 | <0.001 |
Guidelines |
p
| |||||
---|---|---|---|---|---|---|
Yes | No | |||||
n
| % |
n
| % | |||
ASA score | I | 258 | 28.45 | 368 | 25.86 | <0.001 |
II | 509 | 56.12 | 708 | 49.75 | ||
III/IV | 140 | 15.44 | 347 | 24.39 | ||
Defect size | I (<1.5 cm) | 154 | 16.98 | 240 | 16.87 | 0.028 |
II (1.5–3 cm) | 498 | 54.91 | 711 | 49.96 | ||
III (>3 cm) | 255 | 28.11 | 472 | 33.17 | ||
Risk factor | ||||||
Total | Yes | 277 | 30.54 | 559 | 39.28 | <0.001 |
No | 630 | 69.46 | 864 | 60.72 | ||
COPD | Yes | 67 | 7.39 | 149 | 10.47 | 0.012 |
No | 840 | 92.61 | 1274 | 89.53 | ||
Diabetes | Yes | 51 | 5.62 | 114 | 8.01 | 0.028 |
No | 856 | 94.38 | 1309 | 91.99 | ||
Aortic aneurism | Yes | 4 | 0.44 | 11 | 0.77 | 0.329 |
No | 903 | 99.56 | 1412 | 99.23 | ||
Immunosuppression | Yes | 10 | 1.10 | 23 | 1.62 | 0.306 |
No | 897 | 98.90 | 1400 | 98.38 | ||
Corticoid | Yes | 8 | 0.88 | 29 | 2.04 | 0.030 |
No | 899 | 99.12 | 1394 | 97.96 | ||
Smoking | Yes | 111 | 12.24 | 203 | 14.27 | 0.162 |
No | 796 | 87.76 | 1220 | 85.73 | ||
Coagulopathy | Yes | 9 | 0.99 | 40 | 2.81 | 0.003 |
No | 898 | 99.01 | 1383 | 97.19 | ||
Antiplatelet medication | Yes | 79 | 8.71 | 186 | 13.07 | 0.001 |
No | 828 | 91.29 | 1237 | 86.93 | ||
Anticoagulation therapy | Yes | 25 | 2.76 | 50 | 3.51 | 0.313 |
No | 882 | 97.24 | 1373 | 96.49 | ||
EHS-classification medial | Yes | 523 | 57.66 | 795 | 55.87 | 0.394 |
No | 384 | 42.34 | 628 | 44.13 | ||
EHS-classification lateral | Yes | 460 | 50.72 | 800 | 56.22 | 0.009 |
No | 447 | 49.28 | 623 | 43.78 | ||
EHS-classification femoral | Yes | 15 | 1.65 | 32 | 2.25 | 0.319 |
No | 892 | 98.35 | 1391 | 97.75 | ||
EHS-classification scrotal | Yes | 12 | 1.32 | 63 | 4.43 | <0.001 |
No | 895 | 98.68 | 1360 | 95.57 |
Yes | No |
p
| ||||
---|---|---|---|---|---|---|
n
| % |
n
| % | |||
Intraoperative complication | ||||||
Total | Yes | 14 | 1.54 | 23 | 1.62 | 0.891 |
No | 893 | 98.46 | 1400 | 98.38 | ||
Bleeding | Yes | 3 | 0.33 | 12 | 0.84 | 0.131 |
No | 904 | 99.67 | 1411 | 99.16 | ||
Injury | ||||||
Total | Yes | 12 | 1.32 | 14 | 0.98 | 0.447 |
No | 895 | 98.68 | 1409 | 99.02 | ||
Vascular | Yes | 0 | 0.00 | 3 | 0.21 | 0.166 |
No | 907 | 100.0 | 1420 | 99.79 | ||
Bowell | Yes | 0 | 0.00 | 4 | 0.28 | 0.110 |
No | 907 | 100.0 | 1419 | 99.72 | ||
Bladder | Yes | 1 | 0.11 | 1 | 0.07 | 0.748 |
No | 906 | 99.89 | 1422 | 99.93 | ||
Nerve | Yes | 9 | 0.99 | 1 | 0.07 | <0.001 |
No | 898 | 99.01 | 1422 | 99.93 | ||
Postoperative complication | ||||||
Total | Yes | 33 | 3.64 | 82 | 5.76 | 0.021 |
No | 874 | 96.36 | 1341 | 94.24 | ||
Bleeding | Yes | 17 | 1.87 | 45 | 3.16 | 0.060 |
No | 890 | 98.13 | 1378 | 96.84 | ||
Seroma | Yes | 14 | 1.54 | 30 | 2.11 | 0.329 |
No | 893 | 98.46 | 1393 | 97.89 | ||
Infection | Yes | 0 | 0.00 | 3 | 0.21 | 0.166 |
No | 907 | 100.0 | 1420 | 99.79 | ||
Wound healing disorders | Yes | 4 | 0.44 | 7 | 0.49 | 0.861 |
No | 903 | 99.56 | 1416 | 99.51 | ||
Reoperation | Yes | 9 | 0.99 | 30 | 2.11 | 0.041 |
No | 898 | 99.01 | 1393 | 97.89 | ||
Recurrence on follow-up | Yes | 10 | 1.10 | 37 | 2.60 | 0.012 |
No | 897 | 98.90 | 1386 | 97.40 | ||
Pain in rest on follow-up | Yes | 78 | 8.60 | 77 | 5.41 | 0.003 |
No | 829 | 91.40 | 1346 | 94.59 | ||
Pain on exertion on follow-up | Yes | 136 | 14.99 | 145 | 10.19 | <0.001 |
No | 771 | 85.01 | 1278 | 89.81 | ||
Pain requiring treatment on follow-up | Yes | 40 | 4.41 | 50 | 3.51 | 0.274 |
No | 867 | 95.59 | 1373 | 96.49 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
Age (10-year OR) | 0.003 | 1.275 | 1.085 | 1.498 | |
Risk factor | 0.118 | Yes versus no | 1.390 | 0.919 | 2.102 |
Guidelines | 0.155 | Yes versus no | 0.734 | 0.479 | 1.124 |
EHS-classification lateral | 0.165 | Yes versus no | 0.654 | 0.359 | 1.191 |
Defect size | 0.181 | II (1.5–3 cm) versus I (<1.5 cm) | 0.718 | 0.420 | 1.225 |
III (>3 cm) versus I (<1.5 cm) | 1.053 | 0.600 | 1.848 | ||
EHS-classification medial | 0.225 | Yes versus no | 0.685 | 0.372 | 1.262 |
BMI (five-point OR) | 0.392 | 0.880 | 0.656 | 1.180 | |
ASA score | 0.434 | II versus I | 0.742 | 0.439 | 1.256 |
III/IV versus I | 0.913 | 0.470 | 1.775 | ||
EHS-classification femoral | 0.935 | Yes versus no | 0.950 | 0.276 | 3.275 |
EHS-classification scrotal | 0.975 | Yes versus no | 0.985 | 0.371 | 2.612 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
Defect size | 0.006 | II (1.5–3 cm) versus I (<1.5 cm) | 0.521 | 0.346 | 0.786 |
III (>3 cm) versus I (<1.5 cm) | 0.560 | 0.352 | 0.892 | ||
Guidelines | 0.016 | Yes versus no | 1.508 | 1.079 | 2.107 |
BMI (five-point OR) | 0.019 | 1.295 | 1.043 | 1.609 | |
Age (10-year OR) | 0.110 | 0.902 | 0.795 | 1.023 | |
EHS-classification femoral | 0.164 | Yes versus no | 0.238 | 0.032 | 1.798 |
EHS-classification lateral | 0.243 | Yes versus no | 0.716 | 0.409 | 1.254 |
EHS-classification medial | 0.352 | Yes versus no | 0.761 | 0.428 | 1.353 |
ASA score | 0.490 | II versus I | 0.829 | 0.556 | 1.236 |
III/IV versus I | 0.697 | 0.375 | 1.295 | ||
Risk factor | 0.528 | Yes versus no | 1.126 | 0.779 | 1.628 |
EHS-classification scrotal | 0.756 | Yes versus no | 0.839 | 0.276 | 2.545 |
Defect size | All | ||||||||
---|---|---|---|---|---|---|---|---|---|
I (<1.5 cm) | II (1.5–3 cm) | III (>3 cm) | |||||||
N
| % |
N
| % |
N
| % |
N
| % | ||
Guidelines | Pain in rest on follow-up | ||||||||
No | No | 217 | 90.4 | 685 | 96.3 | 444 | 94.1 | 1346 | 94.6 |
Yes | 23 | 9.6 | 26 | 3.7 | 28 | 5.9 | 77 | 5.4 | |
Yes | No | 135 | 87.7 | 455 | 91.4 | 239 | 93.7 | 829 | 91.4 |
Yes | 19 | 12.3 | 43 | 8.6 | 16 | 6.3 | 78 | 8.6 |
Parameter |
p value | Category | OR estimate | 95% CI | |
---|---|---|---|---|---|
Defect size | 0.002 | II (1.5–3 cm) versus I (<1.5 cm) | 0.654 | 0.475 | 0.901 |
III (>3 cm) versus I (<1.5 cm) | 0.517 | 0.355 | 0.754 | ||
Guidelines | 0.010 | Yes versus no | 1.401 | 1.084 | 1.810 |
BMI (five-point OR) | 0.023 | 1.224 | 1.029 | 1.456 | |
Age (10-year OR) | 0.027 | 0.897 | 0.814 | 0.988 | |
EHS-classification scrotal | 0.036 | Yes versus no | 0.211 | 0.049 | 0.900 |
EHS-classification lateral | 0.054 | Yes versus no | 0.653 | 0.423 | 1.007 |
Risk factor | 0.241 | Yes versus no | 1.182 | 0.894 | 1.563 |
EHS-classification femoral | 0.247 | Yes versus no | 0.531 | 0.182 | 1.551 |
EHS-classification medial | 0.292 | Yes versus no | 0.787 | 0.504 | 1.229 |
ASA score | 0.715 | II versus I | 1.054 | 0.769 | 1.446 |
III/IV versus I | 0.905 | 0.563 | 1.453 |
Defect size | All | ||||||||
---|---|---|---|---|---|---|---|---|---|
I (<1.5 cm) | II (1.5–3 cm) | III (>3 cm) | |||||||
N
| % |
N
| % |
N
| % |
N
| % | ||
Guidelines | Pain on exertion on follow-up | ||||||||
No | No | 204 | 85.0 | 644 | 90.6 | 430 | 91.1 | 1278 | 89.8 |
Yes | 36 | 15.0 | 67 | 9.4 | 42 | 8.9 | 145 | 10.2 | |
Yes | No | 121 | 78.6 | 421 | 84.5 | 229 | 89.8 | 771 | 85.0 |
Yes | 33 | 21.4 | 77 | 15.5 | 26 | 10.2 | 136 | 15.0 |